NAUT (Nautilus Biotechnology) Tariff Resilience Score: 4/10 (As of Jul. 02, 2026)


NAUT Nautilus Biotechnology Inc NAUT
28 GF Score
Price $1.84
! 2 Warning Signs
View Full Analysis

What is Nautilus Biotechnology Tariff Resilience Score?

Nautilus Biotechnology NAUT -0.81% 28 Tariff Resilience Score is 4 as of Jul. 02, 2026. GuruFocus rates NAUT with a GF Score™ of 28/100. The stock has 2 warning signs investors should review. Among 1,374 Biotechnology companies, Nautilus Biotechnology ranks better than 52.33% on this metric.

Nautilus Biotechnology has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

Nautilus Biotechnology has Nautilus Biotechnology relies on specialized equipment and materials from international suppliers, making it vulnerable to tariffs. The company has limited pricing power and faces challenges in finding alternative suppliers.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Nautilus Biotechnology might have Average Resilient.


Nautilus Biotechnology  (NAS:NAUT) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Nautilus Biotechnology Tariff Resilience Score Related Terms


NAUT vs IVVD, ACIU, OTLK: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Nautilus Biotechnology's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nautilus Biotechnology Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nautilus Biotechnology's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Nautilus Biotechnology's Tariff Resilience Score falls into.


NAUT
28GF Score
Nautilus Biotechnology Inc NAUT
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
Nautilus Biotechnology (NAUT) has a Tariff Resilience Score of 4 as of Jul. 02, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Nautilus Biotechnology ranks #655 out of 1374 companies in the Biotechnology industry, placing it in the top 47.7%.
Is Nautilus Biotechnology's Tariff Resilience Score too high?
Nautilus Biotechnology's current Tariff Resilience Score is 4. The Biotechnology industry median Tariff Resilience Score is 4.00. Nautilus Biotechnology's value of 4 is 0% at this industry median. Based on the distribution chart, Nautilus Biotechnology ranks #655 out of 1374 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Nautilus Biotechnology has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Nautilus Biotechnology's Tariff Resilience Score compare to IVVD and ACIU?
According to the Biotechnology industry distribution chart, Nautilus Biotechnology ranks #655 out of 1374 companies for Tariff Resilience Score. This puts Nautilus Biotechnology in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Nautilus Biotechnology's value of 4 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,374 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nautilus Biotechnology's current Tariff Resilience Score of 4 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nautilus Biotechnology's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nautilus Biotechnology stock overvalued right now?
Nautilus Biotechnology (NAUT) has a current Tariff Resilience Score of 4. The current Tariff Resilience Score is 4 and 0% at the Biotechnology industry median of 4.00. Nautilus Biotechnology's overall GF Score™ is 28/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Nautilus Biotechnology (NAUT), the current Tariff Resilience Score is 4 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nautilus Biotechnology Business Description

Address 2701 Eastlake Avenue East, Seattle, WA, USA, 98102
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
28GF Score

Get the complete analysis for NAUT

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.84
Price